Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Discov. 2022 Dec 2;12(12):2747-2753. doi: 10.1158/2159-8290.CD-22-1154.
This article presents a review of the major advances and future implications in precision oncology accomplished in 2022 and centers on three primary pillars: advances in (i) rational drug design, (ii) study design, and (iii) novel biomarkers.
本文回顾了 2022 年在精准肿瘤学方面取得的重大进展和未来意义，重点关注三个主要支柱：（i）合理药物设计、（ii）研究设计和（iii）新型生物标志物方面的进展。
